VT News
Mac Schneider

Mac Schneider

Ask VT AI
View News Summary
  • Campbell Soup's Q3 sales rise, but snacks division struggles amid economic uncertainty and higher costs.
  • Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.
  • Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Campbell Soup's Q3 sales rise, but snacks division struggles amid economic uncertainty and higher costs.
  • Sanofi acquires US-based Blueprint Medicines for $9.1 billion, strengthening its portfolio in immunology and rare diseases.
  • Bristol Myers and BioNTech form $11.1B partnership to co-develop next-generation cancer drug BNT327, aiming to accelerate trials and expand indications.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Mac Schneider

Top Topics

Trending in U.S.

World

Sport